{"disease":{"id":"platelet-refractoriness","name":"platelet refractoriness"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03408158","title":"HPA Antibodies and the Distribution of Antigen and Antibodies","phase":"NA","overall_status":"COMPLETED","enrollment_count":6170,"lead_sponsor_name":"Guangzhou First People's Hospital","has_results":false},{"nct_id":"NCT06325553","title":"Incidence of Platelet Refractoriness in Adult Acute Leukemia Patients Receiving Prestorage Filtered Blood and Comparing With Historical Control","phase":"","overall_status":"UNKNOWN","enrollment_count":252,"lead_sponsor_name":"Siriraj Hospital","has_results":false},{"nct_id":"NCT06792019","title":"Study of CM313(SC) Injection in Subjects With Platelet Transfusion Refractoriness","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":110,"lead_sponsor_name":"Keymed Biosciences Co.Ltd","has_results":false},{"nct_id":"NCT03679858","title":"Platelet Antisedimentation Rate and Multiplate Exams in Patients on Antiplatelet Therapy and Controls","phase":"","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"University of Pecs","has_results":false},{"nct_id":"NCT02858323","title":"Complement (C1q) Binding to HLA Antibodies in a Solid-phase Immunoassay and Clinical Effect on Platelet Transfusion","phase":"","overall_status":"COMPLETED","enrollment_count":68,"lead_sponsor_name":"National Institutes of Health Clinical Center (CC)","has_results":false},{"nct_id":"NCT05542134","title":"Platelet Agregation in Patients on ECMO","phase":"","overall_status":"UNKNOWN","enrollment_count":50,"lead_sponsor_name":"University Medical Centre Ljubljana","has_results":false},{"nct_id":"NCT05399693","title":"Platelet Transfusion Refractoriness","phase":"","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Institut de cancérologie Strasbourg Europe","has_results":false},{"nct_id":"NCT05761457","title":"Efficacy and Safety of Autologous Cryopreserved Platelets in Patients With PTR","phase":"NA","overall_status":"UNKNOWN","enrollment_count":25,"lead_sponsor_name":"The First Affiliated Hospital of Soochow University","has_results":false},{"nct_id":"NCT04631211","title":"Thrombosomes® in Bleeding Thrombocytopenic Patients Study","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":21,"lead_sponsor_name":"Cellphire Therapeutics, Inc.","has_results":false},{"nct_id":"NCT06254560","title":"Rituximab for Serious Aplastic Anemia With Platelet Transfusion Refractoriness","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":20,"lead_sponsor_name":"Institute of Hematology & Blood Diseases Hospital, China","has_results":false},{"nct_id":"NCT04846439","title":"Sequential Infusion of CD19 and BCMA CAR-T Cells to Improve PTR in Patients With AL","phase":"PHASE1, PHASE2","overall_status":"UNKNOWN","enrollment_count":20,"lead_sponsor_name":"The First Affiliated Hospital of Soochow University","has_results":false},{"nct_id":"NCT05832216","title":"Efficacy of Daratumumab to Overcome Platelet Transfusion Refractoriness in Patients with Aplastic Anemia","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":10,"lead_sponsor_name":"Institute of Hematology & Blood Diseases Hospital, China","has_results":false},{"nct_id":"NCT02298933","title":"Complement Inhibition Using Eculizumab to Overcome Platelet Transfusion Refractoriness in Patients With Severe Thrombocytopenia","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":10,"lead_sponsor_name":"National Heart, Lung, and Blood Institute (NHLBI)","has_results":true},{"nct_id":"NCT07072247","title":"RN1201 Injection in the Treatment of Antibody-Mediated Diseases","phase":"PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":9,"lead_sponsor_name":"The First Affiliated Hospital of Soochow University","has_results":false},{"nct_id":"NCT05284032","title":"A Pilot Trial Using Isatuximab to Overcome Platelet Transfusion Refractoriness in Human Leukocyte Antigen Allo-Immunized Patients (SuppCare 001)","phase":"EARLY_PHASE1","overall_status":"TERMINATED","enrollment_count":3,"lead_sponsor_name":"Firas El Chaer, MD","has_results":false},{"nct_id":"NCT03712618","title":"The SOLID Platelet Study","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":2,"lead_sponsor_name":"National Institutes of Health Clinical Center (CC)","has_results":true},{"nct_id":"NCT05091684","title":"Administration of Fibrinogen Concentrate for Refractory Bleeding","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":1,"lead_sponsor_name":"Centre Hospitalier Universitaire de Saint Etienne","has_results":false}],"total":17},"guidelines":[],"source":"Drug Landscape verified database"}